Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05155852 · ClinicalTrials.gov registry record
Bedside Monitoring to Identify Impaired Cerebral Autoregulation in Women with Postpartum Hypertension
A clinical trial, sponsored by Columbia University.
- Completed
- Registry status
- 5
- Enrollment target
NCT05155852: Completed study, sponsored by Columbia University.
NCT05155852 is a clinical trial that has completed, run by Columbia University. The registered enrollment target is 5 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05155852 has completed, sponsored by Columbia University.
- COMPLETED
- Registry status
- 5 participants
- Enrollment target
Study Summary
The purpose of this research study is to develop a protocol for NIRS-based bedside monitoring to identify impaired cerebral autoregulation in women admitted to the high-risk obstetrics unit with postpartum hypertension. The investigators will then pilot this protocol in 10 patients with high-risk neurological features, such as headache.
Primary Outcome
The Edwards HemoSphere system with ForeSight Elite NIRS component (Edwards LifeSciences) will be used to monitor oxygenated and deoxygenated hemoglobin concentrations. Two adhesive NIRS probes will be placed on the frontotemporal scalp covering the cortex, usually supplied by the middle cerebral artery. \[Describe how the concentration will be obtained, the range of anticipated concentrations, and how to interpret the concentrations - eg, higher concentrations indicate ...\]
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 5 participants |
| Start Date | 2021-08-13 |
| Est. Completion | 2023-03-13 |
What the finished NCT05155852 record still lists
NCT05155852 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 5 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT05155852 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05155852 about?
NCT05155852 is a clinical study titled "Bedside Monitoring to Identify Impaired Cerebral Autoregulation in Women with Postpartum Hypertension". The purpose of this research study is to develop a protocol for NIRS-based bedside monitoring to identify impaired cerebral autoregulation in women admitted to the high-risk obstetrics unit with postpartum hypertension. The investigators will then pilot this protocol in 10 patients with high-risk ne...
What is the current status of trial NCT05155852?
This trial is currently completed. The enrollment target is 5 participants. The study started on 2021-08-13. Estimated completion is 2023-03-13.
Who is sponsoring clinical trial NCT05155852?
This trial is sponsored by Columbia University, which has 958 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI